chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Fever 102 48 hours after DTaP given. Site at injection very painful/ swollen, seen at ER and treatment for cellulitis at injection site.
I get the Covid jab, now 1 yr later life has changed dramatically; I can not feel the back of my neck and have numbness is both arms and hands, fingers, combined with trigger fingers; I can not feel the back of my neck and have numbness is both arms and hands, fingers, combined with trigger fingers; I can not feel the back of my neck and have numbness is both arms and hands, fingers, combined with trigger fingers; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received BNT162b2 (BNT162B2), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: IMPAIRED QUALITY OF LIFE (non-serious), outcome "unknown", described as "I get the Covid jab, now 1 yr later life has changed dramatically"; FEELING ABNORMAL (non-serious), TRIGGER FINGER (non-serious), HYPOAESTHESIA (non-serious), outcome "unknown" and all described as "I can not feel the back of my neck and have numbness is both arms and hands, fingers, combined with trigger fingers". The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Patient states that area where the vaccine was given started off being very sore. She states that on 8/15/20 hives began on the area that she had received the vaccine. She states today (8/16/20) that the hives have subsided and the area is slightly swollen, has larger red patches around the vaccine site, and is warm to the touch. She states the adverse effects are not bothersome.
We have some Moderna Covid-019 vaccine that was given after the expiration date.; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (We have some Moderna Covid-019 vaccine that was given after the expiration date.) in a 26-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 091D21A) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (We have some Moderna Covid-019 vaccine that was given after the expiration date.). On 03-Nov-2021, EXPIRED PRODUCT ADMINISTERED (We have some Moderna Covid-019 vaccine that was given after the expiration date.) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication provided No treatment medication provided
Felt a mild headache about 4 hours after the injection. Arm soreness as expected. But noticed a rather large (3-4") raised rash mark below the injection site about 4 days after having the vaccine. It was warm and hard and sometime mildly itchy. It lasted for about a week and then completely disappeared. I will also mention that my period was affected by the vaccine. I am normally on schedule to a day but I was late by 1 week. I didn't associate this w/ the vaccine until my sister mentioned that she had the same issue (she also had the Moderna vaccine as well).
patient called 9/19/21,  1 week after 1st moderna dose was given and reported that she had the typical muscle/injection site pain for a day or two, then the following saturday (09/18/21) the deltoid and armpit started swelling, itching, redness, pain. Woke up to worsening side effects today (09/19/21).
Pt received Covid vaccines on 12/31/20, 1/28/21, and a booster on 11/27/21 (all Moderna).  Pt reports that starting after her booster on 11/27/21 she had developed aggressive vitiiligo, though had noted some signs before booster, with first noting of had white patches in ~Oct 2021 on forearms;  after her booster this was progressing over 2-3 weeks in late Nov-early Dec to include forehead/neck/chest/back.
2 hrs p/vax pt would cry 2-3 hrs, stop 20-30mins then cry again for 2-3 hrs; unable to comfort; this lasted for 24-48 hrs; wouldn't eat, diarrhea, limp, shaking, t102 x 3 days;
Following receipt of vaccines in travel clinic client experienced syncope episode, i.e., lost consciousness, became pale, dyaphoretic.  B/P 110/70; client positioned in a reclining position with legs elevated.  Juice and crackers were provided to client following recovery from fainting.  B/P @ 15 min. post-incident:  90/60.  B/P 30 min. post-incident:  100/60.  Client stated he is physically active and typically has a low B/P.   40 min. post-incident client was discharged from clinic with the following instructions:  follow-up with PCP to have pre-travel physical exam, increase salt intake and to eat protein during lunch.  Follow-up phone call on 1/15/09 @ 1645 re:  status of client's condition.  Client stated he "felt fine" and did not experience any problems after discharge from clinic.  State he would follow through with recommendation to see his PCP prior to trave.
Pt vaccinated w/FLU. Developed loss of memory for 2-3 hrs; headache; tired-listless (3 wks post flu shot); tingling extremities; slight occasional palpitations; joint, back & head aches of short duration. No treatment. Still not 100%.
A non-serious spontaneous report of a 66 year old patient received H1N1 LAIV was received from a registered pharmacist/healthcare professional concerning a 66-year-old male. On 16-Dec-2009 the patient received a dose of H1N1, Intranasal. There was no adverse event associated with this vaccination error; therefore, treatment and reporter causality assessments were not applicable and the event was considered resolved.
pt recv vax & exp swollen, red, sore hand x 1wk;pt LMP 12APR96-pregnancy test confirmed pregnancy;ultrasound & vaginal probe confirmed fetal death @ 7 1/2 wk gestation;
Complained of pain in the right deltoid area at site of injection.  Significant swelling, warm and red.  Improved within 2 days.  This is 2nd resident with reaction from same lot and we have saved vial.  There may have been one other resident as well.
This initial spontaneous report was received on 11-SEP-2018 from a lawyer regarding a case in litigation and refers to a male patient of unknown age. Information regarding medical history, concurrent conditions and concomitant medications was not provided. In 2012, the patient was inoculated with ZOSTAVAX at a pharmacy as recommended for routine adult health maintenance and for the prevention of shingles. The vaccine did not prevent shingles as intended, and the patient subsequently contracted a persistent strain of herpes zoster. Later in 2012, the patient was treated at a doctor's office for a vesicular outbreak, which was diagnosed as herpes zoster or shingles. As a direct and proximate result of the ZOSTAVAX vaccine and/or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. Additional information has been requested.
w/in 30hr p/vax devel fever above 104 & sz;taken to ER given ice bath, adm over night to hosp;tested for meningitis-negative;high fever lasted 4 days, then a few days later broke out in rash;since then had sx w/high fever assoc w/ear infect
Dizziness; Joint aches; This is a spontaneous report from a contactable consumer, the patient. A 55-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER2613), via an unspecified route of administration in the left arm on 01Apr2021 at 09:00 (at the age of 55-years-old) as a single dose for COVID-19 immunisation. Medical history was reported as none and the patient had a history of allergy to penicillin. Concomitant medications were not reported. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6208), via an unspecified route of administration in the left arm on 11Mar2021 at 08:45 (at the age of 55-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 01Apr2021 at 21:00, 12 hours after second dose, the patient experienced joint aches and dizziness and still continued for 17 hours at the time of this report. Adverse events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the events joint aches and dizziness was not resolved at the time of this report.  No follow-up attempts are needed. No further information is expected.
Pt came to clinic 10/5/09 and c/o swelling to Rt arm and under armpits. Pt stated that he did not massage his arm. Pt instructed use warm compress to Rt arm.
Child presents with swelling, erythema, painful right arm.  Area from shoulder to elbow feverish, painful to touch and firm to touch.  Mother stated shen noted it about 12 hours after immunization.  (Had DTaP in righ arm on 10/25). Mother had treated with Tylenol and was taking child to pediatritian.
Patient had a vasovagal reaction and passed out.  EMS was called and he was taken to the ED.
Temperature 104.6 (R) at 18:00 PM today. 5/31/06 fussy, Tylenol given-taking fluids well. Exam negative at 19:00 PM other than fever.
Developed a flat red non-itchy rash on upper torso. One pimple like mass did develop but did not become a blister in the upper back.  The rash were 4 mm in diameter.
(L) arm redness; (+) fatigue (+) body aches (+) joint pain; (+) lump on LA.
COLD; ACHY JOINTS; LOW FEVER; MILD HEADACHE; TIRED; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805025, and batch number: 1805025 expiry: 25-MAY-2021) dose was not reported, administered on 09-MAR-2021 12:00 for prophylactic vaccination. No concomitant medications were reported.  On 09-MAR-2021 18:00, the subject experienced cold. On 09-MAR-2021 18:00, the subject experienced achy joints. On 09-MAR-2021 18:00, the subject experienced low fever. On 09-MAR-2021 18:00, the subject experienced mild headache. On 09-MAR-2021 18:00, the subject experienced tired. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from achy joints, low fever, mild headache, tired, and cold. This report was non-serious.
A circular redness around injection site; warm to touch; itching; and painful at injection site.
Redness around site.  Instructed to give Tylenol or Motrin for pain.  Ice pack (PRN) (baseball size).  Pt. (request same arm).  Called 1-16-08, no redness.
I was at a conference away from home. I flew home on Thursday 5/19. When I returned home that afternoon, I felt like I was coming down with a cold. By midday on 5/20 I was feeling worse, but was testing negative on an at home Covid test. I went for a PCR test and the positive results came back Sunday. But by Friday night I was having a lot of symptoms like fever, chills, achiness, sleeplessness, and cough. That Saturday morning, I called an urgent care who prescribed PAXLOVID which I began taking that morning. I have still been experiencing symptoms, but they have been improving. Other than some fatigue, cough, and achiness, I feel as though I am getting better and am overall out of the woods but I still have a few days left of my antiviral to take.
This spontaneous report as received from a medical assistant refers to a 26-year-old male patient. No information regarding the patient's pertinent medical history, concomitant medications, drug reactions, or allergies was provided. The patient was going to receive his second dose of M-M-R II and the second dose of VARIVAX on 01-JUN-2017. On 01-JUN-2017, he received his second dose of M-M-R II (dose, route of administration, lot# and expiration date were not provided) and a dose of ZOSTAVAX (dose, route of administration, lot# and expiration date were not provided) instead of VARIVAX (dose, route of administration, lot# and expiration date were not provided). Additional information is not expected, as there was no consent to contact the reporter.
DEVELOPED FEVER AND CHILLS WITHIN 12 HOURS OF VACCINATION WITH INFLUENZA VACCINE 12/9/03 LASTING FOR ABOUT 12 HOURS. THIS WAS RELIEVED WITH IBUPROFEN 400MG PO Q4-6H X 4 DOSES. 12/11/03, RED RAISED AREA MEASURING 3INCHES X 5INCHES AROUND INJECTION SITE DEVELOPED WITH INCREASED PAIN IN ARM (INCLUDING AXILLA) WHERE VACCINE ADMINISTERED. HAD SAME REACTION AROUND INJECTION SITE WITH TETANUS VACCINE (LOT #U0991AA EXP.4/28/05)9/11/03 AT OFFICE.
Rash, redness, swelling, and itching at injection site (2" diameter) within 2 hours after injection and continues 3 days after.  Chest pains within 1 hour of injection and continued for 1 day.
Itch and rash on left side of neck arm and side. Nometasone Furoate,  Hydroxyzine HCL 25 mg, Prednisone.
Guillain Barre Narrative:  66 y/o male patient received annual influenza vaccine on 9/30/20. Patient began having symptoms on 10/23/20 and was ultimately hospitalized and diagnosed with Guillain Barre at a facility. He received IVIG at this facility for treatment along with PT, OT, speech, and neuropsychological services.
After the first dose, he had mild Flu like symptoms; After the first dose, he had pain in the left arm; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (After the first dose, he had mild Flu like symptoms) and PAIN IN EXTREMITY (After the first dose, he had pain in the left arm) in a 57-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001B21A) for COVID-19 vaccination.     Medical History: Clear and healthy.     On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INFLUENZA LIKE ILLNESS (After the first dose, he had mild Flu like symptoms) and PAIN IN EXTREMITY (After the first dose, he had pain in the left arm). At the time of the report, INFLUENZA LIKE ILLNESS (After the first dose, he had mild Flu like symptoms) and PAIN IN EXTREMITY (After the first dose, he had pain in the left arm) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       No concomitant medications were reported.  Reported that after the first dose, he had minor side effects, pain in the left arm, and mild Flu like symptoms.  No treatment medications were reported.   This case was linked to MOD-2022-537571, MOD-2022-537572, MOD-2022-537573 (Patient Link).
Information has been received from a healthcare worker (medical assistant) referring to unknown number of patients of unknown age and gender. Information about current conditions or medical history was not reported. The healthcare worker reported on unspecified dates the patients received doses of PNEUMOVAX 23 (lot#, dose, route not reported) stored improperly. No adverse effects were reported. This is one of several reports from the same reporter. Additional information has been requested.
aching arm, very warm at injection site, itching large oval red area with raised thickened skin. I HAVE A PHOTO IF NEEDED.
Numbness, tingling, burning, weakness which spread  throughout my body . I?m still  very sick and feel very weak for 10 weeks now .  I Saw multiple drs and was in Emergency Rooms ,  and still have no diagnosis and no treatment. I may still need to seek emergency care  and am still waiting to get another test that will be done in the hospital.
Pain the neck; Runny nose; Body aches; Headache; Chills; Pain at the Injection Site; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of NECK PAIN (Pain the neck), RHINORRHOEA (Runny nose), PAIN (Body aches), HEADACHE (Headache) and CHILLS (Chills) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.   On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.   On an unknown date, the patient experienced NECK PAIN (Pain the neck), RHINORRHOEA (Runny nose), PAIN (Body aches), HEADACHE (Headache), CHILLS (Chills), VACCINATION SITE PAIN (Pain at the Injection Site) and FATIGUE (Fatigue). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency.   At the time of the report, RHINORRHOEA (Runny nose), PAIN (Body aches), HEADACHE (Headache), CHILLS (Chills), VACCINATION SITE PAIN (Pain at the Injection Site) and FATIGUE (Fatigue) was resolving.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   Concomitant product use was not provided by the reporter.
Superior border of macule 3 cm superior of injection site. Large dusky red macular, with amorphous inferior border 12 cm by 6 cm. Secondary light brown secondary coloring covering majority of macule. Patient had palpable induration 6 cm - 5 at site of vaccination. Patient has 2X3 cm of small dense blistering centered at injection site. Overall normal amount of post Tdap tenderness.
This spontaneous report as received from a nurse refers to 10 patients from 11 to 17 years of age. The patients' medical history was not provided. On 04-SEP-2018 (4 doses), 06-SEP-2018 (1 dose), 07-SEP-2018 (1 dose), 11-SEP-2018 (3 doses) and 12-SEP-2018 (1 dose) the patients were vaccinated with improperly stored doses of VARIVAX lot # N034556, expiration date 05-DEC-2019 for prophylaxis. Sterile diluent (manufacturer unknown) was properly stored. The doses underwent a temperature excursion of 47 to 77 degrees Fahrenheit for 15 hours. There was no previous temperature excursion. The digital data logger was involved. No adverse effects were reported.
Gastroenteritis due to COVID-19 virus  Hypokalemia  Diarrhea, unspecified type  Nausea
this is 1 of 5 pt;pt recv vax 23OCT96 & 4hr post vax pt devel body aches;the next day awoke w/body aches & nausea;2 days post vax pt had body aches, diarrhea, anorexia & weight loss;pt began to feel better 3 days post vax & recovery;
Bivalent vaccine was given after 1pm on 9/11/2023 when EUA for this vaccine was removed from EUA use today.  No adverse effect on patient.
Mild rash (estimated 2"x4") expanding from the vaccination site up to 8 days after receiving vaccine. Site with mild tenderness and swelling up to 8 days after receiving vaccine. Photo of rash taken 1/16/21 available upon request.
Within minutes ,felt shooting sharp glass like tingling in fingers on right hand that was felt on and off  for approximately 30 minutes.  Also  raised blood pressure  . One month later , now swelling in right hand pointer and pinky fingers joints . And continued intermittent raised blood pressure levels.
Infant became flushed, then pale; developed raspy sounding respirations, then had bubbled gurgling from her mouth. This lasted 2-5 minutes, then she went limp. The limpness lasted about 45 minutes while they were driving to the ED. Child had no tonic-clonic movements, or opisthotonic posturing. She had no apnea. Upon arrival to the ED, her temp was 102.9, respirations 45, pulse 182, all of which came down with ibuprofen and acetaminophen. Evaluation revealed a bilateral pneumonia.
39 year old male  with right sided facial palsy, symptoms initiated 4/30/21 at 6 am. Patient diagnosed with Bell's Palsy and started on appropriate steroid and antiviral treatment.  Ongoing monitoring currently in progress.
She feels that she is having covid like symptoms; This week she started with heavy mucus; She started with slight wheezing a week later; She had a sore arm for 1 week after receiving 1st dose; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 07-Apr-2021 and was forwarded to Moderna on 07-Apr-2021.    This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (She had a sore arm for 1 week after receiving 1st dose), WHEEZING (She started with slight wheezing a week later), SECRETION DISCHARGE (This week she started with heavy mucus) and COVID-19 (She feels that she is having covid like symptoms) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 045A21A) for COVID-19 vaccination.     Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID), FENOFIBRATE, IRBESARTAN and DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE (FARXIGA) for an unknown indication.    On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 milliliter. On 18-Mar-2021, the patient experienced PAIN IN EXTREMITY (She had a sore arm for 1 week after receiving 1st dose). On 25-Mar-2021, the patient experienced WHEEZING (She started with slight wheezing a week later). On 05-Apr-2021, the patient experienced SECRETION DISCHARGE (This week she started with heavy mucus). On 07-Apr-2021, the patient experienced COVID-19 (She feels that she is having covid like symptoms). The patient was treated with ALBUTEROL SULFATE at a dose of 1 dosage form. At the time of the report, PAIN IN EXTREMITY (She had a sore arm for 1 week after receiving 1st dose), WHEEZING (She started with slight wheezing a week later), SECRETION DISCHARGE (This week she started with heavy mucus) and COVID-19 (She feels that she is having covid like symptoms) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Most recent FOLLOW-UP information incorporated above includes: On 08-Jul-2021: Follow-up received on 08-JUL-2021 contains Non-Significant information.
Pt's left arm became red, swollen and hot to the touch the next day at 1700. Pt went to the ER c/o difficulty breathing. She was given epinephrine Methylprednisolone ranitidine, albuterol, diphenhydramine. Pt was monitored overnight and released the next morning.
Child developed rigors and/or seizures accompanied by period of deep pallor/cyanosis although perceived by mother to be moving extremities and having heat beat; on arrival to Emergency Dept she was 104.7 degrees with a pulse >200 beats/min.
Vesicular rash in clusters on left upper arm in area where MENACTRA and TRUMENBA vaccines were administered on 05/04/2018. Differential might be herpetic rash, skin reaction secondary to immunizations, photodermasitis.
Patient began to have whelps and itching all over her body the Sunday after her vaccines were administered.  She began treating with Benadryl and topical Calamine . She does not believe that she was exposed to anything doing yard work. Her itching has improved and is now isolated to her wrists and hands.  Encouraged her to continue using Benadryl and to contact her Physician if symptoms do not improve or worsened
Fever. Cerebellar ataxia - unsteady gait, poor balance. Referred to neurologist.
Pt recvd a series of Engerix-B on 11FEB88, 18jAMR88, 29SEP88 respectively; Titers drawn 17APR91 revealed pt had low protection; Booster dose may be given;